XML 55 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Reporting
6 Months Ended
Jun. 30, 2014
Segment Reporting [Abstract]  
Segment Reporting [Text Block]
Segment Reporting
The company discloses certain financial and supplementary information about its reportable segments, revenue by products and revenues by geographic area. Operating segments are defined as components of an enterprise about which separate discrete financial information is evaluated regularly by the chief operating decision maker, in order to decide how to allocate resources and assess performance. The primary performance indicators for the chief operating decision maker are sales and operating income, with sales presented on a ship-from basis. All references to sales in this Form 10-Q, either on a ship-from or ship-to basis, are on the same basis of revenue recognition and are recognized when title and risk of loss passes to the customer, which occurs either upon shipment or delivery, depending upon the agreed sales terms with customers.
The Company's reportable segments reflect the core businesses in which Innophos operates and how it is managed. The Company reports its core specialty phosphates business separately from granular triple super-phosphate, or GTSP, and other non-specialty phosphate products (GTSP & Other). Kelatron, AMT, CMI and Triarco are included in the Specialty Phosphates US & Canada segment and in the Specialty Ingredients product line. Specialty Phosphates consists of the products lines Specialty Ingredients, Food & Technical Grade PPA, and STPP & Detergent Grade PPA. GTSP & Other includes fertilizer co-product GTSP and other non-specialty phosphate products.

For the three months ended June 30, 2014
 
Specialty
Phosphates
US & Canada
 
Specialty
Phosphates
Mexico
 
GTSP &
Other
 
Eliminations
 
Total
Sales
 
$
157,267


$
40,885


$
21,390


$
—


$
219,542

Intersegment sales
 
796


15,139


38


(15,973
)

—

Total sales
 
$
158,063


$
56,024


$
21,428


$
(15,973
)

$
219,542

Operating income
 
$
21,334


$
10,320


$
155


$
—


$
31,809

Depreciation and amortization expense
 
$
6,291


$
2,277


$
357


$
—


$
8,925

 
 
 
 
 
 
 
 
 
 
 
For the three months ended June 30, 2013
 
Specialty
Phosphates
US & Canada
 
Specialty
Phosphates
Mexico
 
GTSP &
Other
 
Eliminations
 
Total
Sales
 
$
159,054

 
$
43,370

 
$
10,752

 
$
—

 
$
213,176

Intersegment sales
 
778

 
14,860

 
128

 
(15,766
)
 
—

Total sales
 
$
159,832

 
$
58,230

 
$
10,880

 
$
(15,766
)
 
$
213,176

Operating income
 
$
23,759

 
$
1,333

 
$
(2,962
)
 
$
—

 
$
22,130

Depreciation and amortization expense
 
$
6,465

 
$
2,318

 
$
682

 
$
—

 
$
9,465

 
 
 
 
 
 
 
 
 
 
 
For the six months ended June 30, 2014
 
Specialty
Phosphates
US & Canada
 
Specialty
Phosphates
Mexico
 
GTSP &
Other
 
Eliminations
 
Total
Sales
 
$
308,277

 
$
85,374

 
$
42,232

 
$
—

 
$
435,883

Intersegment sales
 
1,550

 
27,757

 
39

 
(29,346
)
 
—

Total sales
 
$
309,827

 
$
113,131

 
$
42,271

 
$
(29,346
)
 
$
435,883

Operating income
 
$
41,547

 
$
16,181

 
$
(3,975
)
 
$
—

 
$
53,753

Depreciation and amortization expense
 
$
11,609

 
$
5,046

 
$
744

 
$
—

 
$
17,399

 
 
 
 
 
 
 
 
 
 
 
For the six months ended June 30, 2013
 
Specialty
Phosphates
US & Canada
 
Specialty
Phosphates
Mexico
 
GTSP &
Other
 
Eliminations
 
Total
Sales
 
$
310,045

 
$
82,285

 
$
35,287

 
$
—

 
$
427,617

Intersegment sales
 
1,301

 
27,123

 
239

 
(28,663
)
 
—

Total sales
 
$
311,346

 
$
109,408

 
$
35,526

 
$
(28,663
)
 
$
427,617

Operating income (a) (b)
 
$
34,551

 
$
1,990

 
$
3,514

 
$
—

 
$
40,055

Depreciation and amortization expense
 
$
13,572

 
$
4,076

 
$
1,203

 
$
—

 
$
18,851



(a)
The six months ended June 30, 2013 includes a $7.2 million benefit to earnings related to updates to the provision for the CNA Fresh Water Claims in GTSP & Other.
(b)
The six month period ended June 30, 2013 includes a $2.3 million charge to earnings for out of period costs in the US.